Wednesday, September 1, 2010
%excerpt%
Link:
Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing
Also filed in
|
|
Wednesday, September 1, 2010
%excerpt%
See the article here:
Contingency management treatments: controversies and challenges
Also filed in
|
|
Wednesday, September 1, 2010
%excerpt%
Read the original post:
Commentary on Merrall et al. (2010): Understanding mortality and health outcomes for ex-prisoners – first steps on a long road
Also filed in
|
|
Wednesday, September 1, 2010
%excerpt%
See original here:
Commentary on Norstrm & Pape (2010): Unleashing the beast within? Suppressed anger and changes in drinking and fighting
Also filed in
|
|
Wednesday, September 1, 2010
%excerpt%
More here:
Commentary on Nelson et al. (2010): The many sources of survey under-coverage
Also filed in
|
|
Wednesday, September 1, 2010
Aims Naltrexone is a competitive opioid antagonist that effectively blocks the action of heroin and other opioid agonists.
Also filed in
|
|
Wednesday, September 1, 2010
%excerpt%
Here is the original post:
Commentary on Joossens et al. (2010): Eliminating the global illicit cigarette trade – what do we really know?
Also filed in
|
|
Wednesday, September 1, 2010
Aims To examine the association of adolescent depression and anxiety symptoms with daily smoking and nicotine dependence in young adulthood.Design A prospective cohort study of adolescent and young adult health (n = 1943). Teen assessments occurred at 6-monthly intervals, with two follow-up assessments in young adulthood (wave 7, 1998; wave 8, 2001–03).Setting Victoria, Australia.Participants Students who participated at least once during the first six (adolescent) waves of the cohort study.Measurements Adolescent depression and anxiety symptoms were assessed using the Revised Clinical Interview Schedule (CIS-R). Young adult tobacco use was defined as: daily use (6 or 7 days per week) and dependent use (4 on the Fagerstrom Test for Nicotine Dependence).Findings Among adolescent less than daily’ smokers, those with high levels of depression and anxiety symptoms had an increased risk of reporting nicotine dependence in young adulthood [odds ratio (OR) 3.3, 95% confidence interval (CI) 1.2–9.1] compared to young adults who had low levels of adolescent depression and anxiety symptoms, after adjusting for potential confounding factors.
Wednesday, September 1, 2010
Aims To examine the effectiveness of transdermal selegiline for producing cigarette smoking abstinence.Design Adult smokers were randomly assigned to receive selegiline transdermal system (STS) or placebo given for 8 weeks. All participants received cognitive behavior therapy (CBT).
Also filed in
|
|
Wednesday, September 1, 2010
%excerpt%
Read the rest here:
New Books
Also filed in
|
|